Home > Customer > Notice/News
 
 
35   eTEC E & C Ltd. announced that it was selected by Tuberculosis Research Institute of Korea National Tuberculosis Association as an eligible company. Admin 2007-12-26 2586
 
 
 
eTEC E & C Ltd.( President, Oh Chang-Suk ) announced on Dec. 21,2007 that it was selected by Tuberculosis Research Institute of Korea National Tuberculosis Association as an eligible company who would perform detail engineering and construction works for BCG Vaccine producing facility and new tuberculosis research building with the contract amount of 11.3 billion won. It will be located, having the site of 9917.4 m2, within O-Song Life Science Complex addressed at 15-1, Chungwon-Gun, Chungcheong Buk-Do.
 
eTEC will perform this Project as a Turn-Key basis from the design, construction to commissioning of BCG Vaccine facility and Tuberculosis Research building to be fitted for the standard of cGMP as well as BSL-3. The construction will take 21 months planning to start from January 2008 to September 2009.  
 
This project, as the largest scale of BCG Vaccine producing facility ever built to date in Korea, shall meet the standard both of cGMP and BSL-3. eTEC could be selected as an eligible company by being appreciated for its yearlong experience and accumulated technology on the field of biological pharmaceutical production facilities.  eTEC, by the opportunity of executing this Project, will be able to  make a stepping stone that enables to get the similar facility projects in the future in domestic as well as in abroad for Vaccine producing and Biological Facility being exposed under such high risks.
 
 
  Middle-East Branch Office Founded
  eTEC E&C Ltd. has won a contract to build a H2 plant of DC Chemical co Ltd.